semaglutide glp-1 99.00 | --- 5 mg / 2 ml --- 2 ml vial --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) GLP-1 Prescription Medications: Uses and

Very common (10% of patients) Nausea peaks during titration, typically subsides within 48 weeks at a stable dose Vomiting, diarrhoea, constipation Abdominal pain or discomfort Reduced appetite (this is the therapeutic effect, not an adverse effect) Less common but serious stop and see a doctor Severe, persistent abdominal pain radiating to the back possible pancreatitis Right upper abdomen pain, fever, yellowing possible gallstones / gallbladder disease Persistent neck lump, hoarseness, difficulty swallowing evaluate thyroid Rapid heartbeat, severe dehydration from vomiting Hypoglycaemia when semaglutide is combined with insulin or sulfonylureas What the Indian data shows: a 2025 study of Indian patients found GI side effects are the leading cause of discontinuation, peaking during dose escalation

Lim JJ, Poppitt SD

Step 4: Go Live with Confidence Start processing payments using a system designed specifically for high-risk compliance

The next GLP-1 indicated for type 2 diabetes to lose exclusivity is Trulicity (dulaglutide) in 2027

Along with the 12% who have tried the drugs, another 14% are interested in giving them a go, the survey found